Discovery of KIN-3248, An Irreversible, Next Generation FGFR Inhibitor for the Treatment of Advanced Tumors Harboring FGFR2 and/or FGFR3 Gene AlterationsJohn Tyhonas, Stephen W. Kaldor, Elisabeth Gardiner et al.|Journal of Medicinal Chemistry|2024Cited by 18
Discovery of KIN-8741, a Highly Selective Type IIb c-Met Kinase Inhibitor with Broad Mutation Coverage and Quality Drug-Like Properties for the Treatment of CancerXiaohu Ouyang, Jason M. Cox, Kathryn B. Grandinetti et al.|Journal of Medicinal Chemistry|2025Cited by 1